SCHEMBL7679970

SCHEMBL7679970

CN1CCN(Cc2[c]ccnc2Cl)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 1/20 0.42
▸ LMNA P02545 1/20 0.40
▸ METAP2 P50579 1/20 0.39
▸ CHKA P35790 3/20 0.38
▸ KDM4E B2RXH2 3/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.38
▸ CA2 P00918 1/20 0.36
▸ NCF1 P14598 1/20 0.36
▸ PRMT6 Q96LA8 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ TMEM97 Q5BJF2 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ TP53 P04637 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7678922 0.78 HRH3 (0.39) MC4RLMNACHKAKDM4EHRH3
SCHEMBL7679625 0.78 HRH3 (0.39) MC4RLMNACHKAKDM4EHRH3
SCHEMBL7682554 0.77 HRH4 (0.41) CYP1A2CYP2D6NPC1RAB9AHRH4
SCHEMBL7680859 0.76 HTR2C (0.38) —
SCHEMBL27501203 0.75 CHIA (0.35) LMNAMETAP2KDM4EHRH3CYP2D6
SCHEMBL7681200 0.74 KDM4E (0.32) MC4RLMNAKDM4E
SCHEMBL27455478 0.74 KDM4A (0.34) MC4RLMNAMETAP2KDM4EALDH1A1
SCHEMBL27471040 0.73 PDE10A (0.39) HRH3
SCHEMBL7681799 0.71 JAK3 (0.37) LMNACHKAKDM4EALDH1A1NPC1
SCHEMBL19561794 0.71 METAP2 (0.56) MC4RLMNAMETAP2CHKAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 — — US disclosed
Send feedback